Immunochemicals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
- Transparency Market Research
Immunochemicals are used to analyze various reactions and components of molecular mechanism. They are quality products with high specificity and selectivity and are developed for a wide range of applications in medical, pharmaceutical, and life science research. Immunochemicals are used in drug discovery, therapeutics, imaging, assay components, and as a research tools. They are also used to develop personalized medicine and protein therapeutics and to identify new targets to treat various chronic diseases. The global immunochemicals market is projected to expand at a significant CAGR during the forecast period owing to increasing research and development initiatives, rise in government funding in drug discovery and proteomic research, increase in incidence of chronic diseases, and rise in collaboration between industries and research institutes. Furthermore, increase in demand for personalized medicine and protein therapeutics, increased focus on drugs safety and efficacy, and identification of new targets for disease treatment are likely to boost the expansion of the market. However, high cost and stringent regulatory environment are factors restraining the global immunochemicals market.
The global immunochemicals market can be segmented based on research area, application, end-user, and geography. Based on research area, the global immunochemicals market can be classified into autoimmune diseases, oncology, neurology, infectious diseases, metabolic diseases, and others. The infectious diseases segment, followed by the oncology segment, is expected to expand during forecast period owing a large patient base, increase in demand for targeted therapy, and rising research and development expenditure. In terms of application, the global immunochemical market can be segmented into drug discovery & development, proteomics, and genomics. The proteomic segment is expected to account for a prominent share of the market due to utilization of proteomic-based approaches in cancer profiling and biomarker detection and availability of funds from various research organizations. Based on end-user, the global immunochemical market can be divided into pharmaceutical and biotechnological companies, academic and research institutes, and others. The pharmaceutical and biotechnological companies segment is expected to hold significant share during the forecast period due to higher uptake of immunochemicals in the new drug discovery and development process.
In terms of geography, the global immunochemicals market can be categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The market in North America is anticipated to be dominant, followed by Europe. Increasing incidence and prevalence of chronic diseases, well-established health care infrastructure, presence of a large number of biopharmaceutical companies and research institutes, increased research and development expenditure, higher adoption of advanced technologies, and higher health care spending are likely to propel the expansion of the global immunochemicals market in North America and Europe. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period. The expansion is expected to be driven by presence of a large patient base suffering from chronic diseases such as cancer and rheumatoid arthritis in India and China, increasing demand for personalized medicine, increased government initiatives toward improving health, and developing health care infrastructure. The immunochemicals market in Latin America and Middle East & Africa is anticipated to expand during the forecast period, owing to increase in investments from major market players in these regions.
Leading players in the global immunochemicals market include Thermo Fisher Scientific, Inc., Rockland Immunochemicals Inc., Advanced ImmunoChemical, Inc., Immundiagnostik AG, LGC Biosearch Technologies, Becton, Dickinson and Company, LAMPIRE Biological Laboratories, Inc., Antibodies Inc., and Agilent Technologies.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017